AZOPT

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States

Active ingredients

The drug AZOPT contains one active pharmaceutical ingredient (API):

1 Brinzolamide UNII 9451Z89515 - BRINZOLAMIDE

Brinzolamide is an inhibitor of carbonic anhydrase II (CA-II). Carbonic anhydrase (CA) is an enzyme found in many tissues of the body, including the eye. Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humour secretion resulting in a reduction in intraocular pressure (IOP) which is a major risk factor in the pathogenesis of optic nerve damage and glaucomatous visual field loss. Read about Brinzolamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AZOPT Eye drops, suspension	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01EC04	Brinzolamide	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EC Carbonic anhydrase inhibitors
Discover more medicines within S01EC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5540N, 8483L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 500900401178310
Country: CA	Health Products and Food Branch	Identifier(s): 02238873
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00432768, 00587666, 00587672, 00698130, 02477373, 02477396, 03963124, 04649306, 05026990, 05027050, 05485048, 05485054, 06455552, 06455569, 06920279, 09671546, 10297604, 11613970, 11730463, 12500297, 17277875, 17558491
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 26.185-02-05
Country: EE	Ravimiamet	Identifier(s): 1042782, 1213074, 1213085
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 00129001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 566182
Country: FR	Base de données publique des médicaments	Identifier(s): 60868670
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 138440, 14038, 374305
Country: HK	Department of Health Drug Office	Identifier(s): 49989
Country: IE	Health Products Regulatory Authority	Identifier(s): 50701, 50724, 50789, 50808, 50816
Country: IT	Agenzia del Farmaco	Identifier(s): 034770014
Country: JP	医薬品医療機器総合機構	Identifier(s): 1319748Q1036
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003697, 1027610, 1027611
Country: NG	Registered Drug Product Database	Identifier(s): 04-6817
Country: NL	Z-Index G-Standaard	Identifier(s): 14656612
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 72877
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8931
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100100945
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64500001, W64500002, W64500003
Country: SG	Health Sciences Authority	Identifier(s): 11029P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 20833011
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504710113
Country: US	FDA, National Drug Code	Identifier(s): 0065-0275